Filter your results
- 2
- 1
- 3
- 3
- 2
- 1
- 3
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
Granulocyte/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active ulcerative colitisScandinavian Journal of Gastroenterology, 2018, 53 (4), pp.442-448. ⟨10.1080/00365521.2018.1447598⟩
Journal articles
hal-01880990v1
|
|||
|
Safety and efficacy of granulocyte/monocyte apheresis in steroid-dependent active ulcerative colitis with insufficient response or intolerance to immunosuppressants and/or biologics (ART trial): 12-week interim resultsJournal of Crohn's & Colitis, 2016, 10 (7), pp.812-820. ⟨10.1093/ecco-jcc/jjw032⟩
Journal articles
hal-01269897v1
|
||
|
ALK IHC and FISH discordant results in patients with NSCLC and treatment response For discussion of the question - To treat or not to treat?European Society for Medical Oncology, 2018, 3 (6), pp.e000419. ⟨10.1136/esmoopen-2018-000419⟩
Journal articles
hal-01905212v1
|